Haemonetics Corporation · NYSE:HAE
Simon, Christopher received 78,344 Haemonetics Corporation shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Simon, Christopher (Director, President & CEO) received 78,344 Haemonetics Corporation shares as an award, leaving 444,704 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 78,344 shares
- Holding after
- 444,704 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Shares withheld for tax | 9,681 | US$56.29 | 366,360 | Direct |
| May 15, 2026 | Common Stock | Award | 78,344 | 444,704 | Direct |